Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Vijay K. Singh, Meera Srivastava & Thomas M Seed. (2023) Protein biomarkers for radiation injury and testing of medical countermeasure efficacy: promises, pitfalls, and future directions. Expert Review of Proteomics 20:10, pages 221-246.
Read now
Read now
Hong-Soo Lee, Doo-Wan Cho, Ji-Seok Han, Su-Cheol Han, Sang Keun Woo, Soo-Youn Jun, Woo-Jong Lee, Susie Yoon, Son-Il Pak, Sang-Jin Lee, Eunsol Seong & Eun-Jung Park. (2020) KMRC011, an agonist of toll-like receptor 5, mitigates irradiation-induced tissue damage and mortality in cynomolgus monkeys. Journal of Immunotoxicology 17:1, pages 31-42.
Read now
Read now
Vijay K. Singh, Thomas M. Seed & Ayodele O. Olabisi. (2019) Drug discovery strategies for acute radiation syndrome. Expert Opinion on Drug Discovery 14:7, pages 701-715.
Read now
Read now
Vijay K. Singh, Briana K. Hanlon, Paola T. Santiago & Thomas M. Seed. (2017) A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part III. Countermeasures under early stages of development along with ‘standard of care’ medicinal and procedures not requiring regulatory approval for use. International Journal of Radiation Biology 93:9, pages 885-906.
Read now
Read now
Vijay K. Singh, Patricia L.P. Romaine, Victoria L. Newman & Thomas M. Seed. (2016) Medical countermeasures for unwanted CBRN exposures: part II radiological and nuclear threats with review of recent countermeasure patents. Expert Opinion on Therapeutic Patents 26:12, pages 1399-1408.
Read now
Read now
Mahesh Chandra Patra & Sangdun Choi. (2016) Recent progress in the development of Toll-like receptor (TLR) antagonists. Expert Opinion on Therapeutic Patents 26:6, pages 719-730.
Read now
Read now
Articles from other publishers (9)
Thifhelimbilu Luvhengo, Uzayr Khan & Thomas Kekgatleope Marumo. (2023) Paneth Cells and Lgr5+ Intestinal Stem Cells in Radiation Enteritis. Applied Sciences 13:5, pages 2758.
Crossref
Crossref
Shyam Babu Prasad & Rahul Kumar. 2021. Cell Interaction - Molecular and Immunological Basis for Disease Management. Cell Interaction - Molecular and Immunological Basis for Disease Management.
Zahra Shaghaghi, Maryam Alvandi, Sahar Nosrati & Seyed Kamaledin Hadei. (2021) Potential utility of peptides against damage induced by ionizing radiation. Future Oncology 17:10, pages 1219-1235.
Crossref
Crossref
Vijay K. Singh & Thomas M. Seed. (2021) Entolimod as a radiation countermeasure for acute radiation syndrome. Drug Discovery Today 26:1, pages 17-30.
Crossref
Crossref
Keywan Mortezaee, Dheyauldeen Shabeeb, Ahmed E. Musa, Masoud Najafi & Bagher Farhood. (2019) Metformin as a Radiation Modifier; Implications to Normal Tissue Protection and Tumor Sensitization. Current Clinical Pharmacology 14:1, pages 41-53.
Crossref
Crossref
Sweta Sanguri & Damodar Gupta. (2018) Mannan oligosaccharide requires functional ETC and TLR for biological radiation protection to normal cells. BMC Cell Biology 19:1.
Crossref
Crossref
Maryam A. Shetab Boushehri & Alf Lamprecht. (2018) TLR4-Based Immunotherapeutics in Cancer: A Review of the Achievements and Shortcomings. Molecular Pharmaceutics 15:11, pages 4777-4800.
Crossref
Crossref
Min-Sung Kang, Min-Seok Kim, Sung-Hwan Kim, Doin Jeon, Hyeon-Young Kim, Kwang-Hyun Lim, Su-Cheol Han, Kyuhong Lee, Woo-Jong Lee, Chi-Min Choi, Hong-Soo Lee & Jong-Choon Kim. (2018) Subacute toxicity evaluation of KMRC011, a Toll-like receptor-5 agonist administered by intramuscular injection to rats. Fundamental Toxicological Sciences 5:1, pages 33-48.
Crossref
Crossref
Mohammad Zahid Kamran, Atul Ranjan, Navrinder Kaur, Souvik Sur & Vibha Tandon. (2016) Radioprotective Agents: Strategies and Translational Advances. Medicinal Research Reviews 36:3, pages 461-493.
Crossref
Crossref